Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Arthritis : a self-help guide to feeling better / / Wendy Green ; foreword by Susan Oliver
| Arthritis : a self-help guide to feeling better / / Wendy Green ; foreword by Susan Oliver |
| Autore | Green Wendy |
| Pubbl/distr/stampa | Chichester, England : , : Summersdale Publishers Ltd, , 2016 |
| Descrizione fisica | 1 online resource (208 pages) |
| Disciplina | 616.72206 |
| Collana | Personal Health Guides |
| Soggetto topico |
Arthritis - Treatment
Arthritis Arthritis - Nutritional aspects |
| ISBN |
1-78372-697-0
1-78372-695-4 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910157367103321 |
Green Wendy
|
||
| Chichester, England : , : Summersdale Publishers Ltd, , 2016 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Bioactive food as dietary interventions for arthritis and related inflammatory diseases [[electronic resource] /] / edited by Ronald Ross Watson and Victor R. Preedy
| Bioactive food as dietary interventions for arthritis and related inflammatory diseases [[electronic resource] /] / edited by Ronald Ross Watson and Victor R. Preedy |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Boston, : Elsevier, 2013 |
| Descrizione fisica | xxv, 654 p. : ill. (some col.) |
| Disciplina | 616/.0473 |
| Altri autori (Persone) |
WatsonRonald R (Ronald Ross)
PreedyVictor R |
| Collana | Bioactive foods in chronic disease states |
| Soggetto topico |
Arthritis - Nutritional aspects
Inflammation Bioactive compounds |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910795189703321 |
| Boston, : Elsevier, 2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Bioactive food as dietary interventions for arthritis and related inflammatory diseases / / edited by Ronald Ross Watson and Victor R. Preedy
| Bioactive food as dietary interventions for arthritis and related inflammatory diseases / / edited by Ronald Ross Watson and Victor R. Preedy |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Boston, : Elsevier, 2013 |
| Descrizione fisica | xxv, 654 p. : ill. (some col.) |
| Disciplina |
616/.0473
616.0473 |
| Altri autori (Persone) |
WatsonRonald R (Ronald Ross)
PreedyVictor R |
| Collana | Bioactive foods in chronic disease states |
| Soggetto topico |
Arthritis - Nutritional aspects
Inflammation Bioactive compounds |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover -- Acknowledgments for Bioactive Foods in Chronic Disease States -- Bioactive Food as Interventions for Arthritis and Related Inflammatory Diseases -- Copyright -- Contents -- Preface: Arthritis and Inflammation -- Contributors -- Chapter 1: Antioxidant Flavonoids for Arthritis Treatment: Human and Animal Models -- Abbreviations -- 1.Introduction to Phytoflavonoids -- 2.What Is Arthritis? -- 3.Osteoarthritis -- 4.Rheumatoid Arthritis -- 5.Flavonoids -- 6.Animal Models of Acute and Chronic Inflammation -- 7.Flavonoids and Its Effect on Animal Model Arthritis -- 8.Radiographic Analysis of Adjuvant-Induced Arthritis -- 9.Flavonoids Devoid of Toxic Effects -- 10.Clinical Trial of Flavonoids on Arthritis -- 11.The Mechanism of Actions of Flavonoids -- Acknowledgment -- References -- Chapter 2: Inflammation in Arthritis -- Abbreviations -- 1.Introduction -- 2.Mechanism of Inflammation in Arthritis -- 3.Dairy Products and Inflammation -- 4.Effects of Food and Spices in Inflammation -- 5.The Role of PUFA in Arthritis -- 6.Antioxidants and Inflammation in Arthritis -- 7.Summary -- References -- Chapter 3: Effects of Beef on Inflammation Affecting Arthritis -- Abbreviations -- 1. Introduction -- 1.1. Arthritis -- 1.1.1. Overview -- 1.1.2. Prevalence -- 1.1.3. Disability -- 1.1.4. Treatment -- 1.2. Beef -- 1.2.1. Overview -- 1.2.2. Nutrients -- 1.2.2.1.1. Polyunsaturated Fatty Acids -- 1.2.2.1.2. Monounsaturated Fatty Acids -- 1.2.2.1.3. Saturated Fatty Acids -- 1.2.2.1.4. Cholesterol -- 2. Arthritis and Diet -- 2.1. Osteoarthritis -- 2.1.1. Overview -- 2.1.2. Prevention -- 2.1.3. Treatment -- 2.1.4. Discussion -- 2.2. Rheumatoid Arthritis -- 2.2.1. Overview -- 2.2.2. Nutrition status -- 2.2.3. Prevention -- 2.2.4. Foods associated with symptom aggravation -- 2.2.5. Treatment -- 2.2.5.2.1. PUFAs -- 2.2.5.2.2. MUFAs -- 2.2.5.2.3. Protein.
2.2.6. Discussion -- 2.3. Gout -- 2.3.1. Overview -- 2.3.2. Prevention -- 2.3.3. Treatment -- 2.3.4. Discussion -- 3. Contraindications of Beef -- 3.1. Cancer -- 3.2. Heart Disease -- 4. Dietary Recommendations of Beef -- 5. Conclusions -- Definitions -- References -- Further Reading -- Chapter 4: Contribution of Bioactive Foods and Their Emerging Role in Immunomodulation, Inflammation, and Arthritis -- Abbreviations -- 1. Bioactive Food Components -- 2. Immunomodulation -- 2.1. Flavan-3-ols -- 2.2. Isoflavones -- 2.3. Flavones, Flavonols, and Relevant Nonflavonoid Polyphenols -- 2.4. Chalcones -- 3. Arthritis -- 3.1. Flavan-3-ols -- 3.2. Flavones, Flavanones, Isoflavones, and Flavonols -- 3.3. Anthocyanins -- 4. Inflammation -- 4.1. Flavan-3-ols -- 4.2. Isoflavones -- 4.3. Flavones, Flavanones, and Flavonols -- 4.4. Anthocyanins -- References -- Chapter 5: Curcumin and Joint Health: From Traditional Knowledge to Clinical Validation -- Abbreviations -- 1. Introduction -- 2. Clinical Relevance of Osteoarthritis -- 3. Prevalence and Causes of OA -- 4. Current OA Treatments -- 5. Preclinical and Clinical Evidence of Activity for Curcumin in the Treatment of OA -- 6. The Bioavailability Issue -- 7. The Development of a Novel Curcumin-Phospholipid Complex (Meriva) -- 8. Clinical Efficacy of Curcumin and of Meriva in the Management of Osteoarthrosis -- 9. Conclusions -- References -- Chapter 6: Dried Plum and Bone Health -- Abbreviations -- 1. Introduction -- 2. Plant-Based Foods and Bone Health -- 3. Bone Remodeling -- 4. Role of Inflammation in Bone Loss -- 5. Oxidative Stress and Bone -- 6. Dried Plums -- 7. Dried Plums Prevent Bone Loss -- 8. Dried Plum Restores Bone -- 9. Clinical Studies, Dried Plum and Bone -- 10. Dried Plum, Bone and Inflammation -- 11. Conclusions -- Glossary -- References -- Further Reading -- Relevant Websites. Chapter 7: The Alkaline Way: Integrative Management of Rheumatoid Arthritis and Other Autoimmune Conditions -- 1. An Integrative Approach -- 1.1. Evaluating Markers of Inflammation, Detoxification, and Immune Function -- 1.2. Testing for Delayed Antigen Reactions to Food and Chemicals -- 1.2.1. Antibody assays -- 1.2.2. Immune complexes -- 1.2.3. Lymphocyte response assays -- 1.2.4. Comparative methodology -- 1.2.5. Accuracy of functional immunology tests -- 2. Restoring Alkaline Balance -- 2.1. The Alkaline Diet -- 2.1.1. The importance of reducing acidity in the body -- 2.1.2. Reducing inflammation -- 2.1.3. Increasing nutrient levels -- 2.1.4. Improving health, functionality, and symptoms -- 2.1.5. Enhancing immune defenses -- 2.2. Alkaline Nutrients -- 2.3. Self-Testing for Alkaline Status -- 3. Self-Care -- 3.1. Physical Fitness and Immune Competence -- 3.2. Mindfulness Practice and Immunity -- 4. Discussion -- 5. Conclusions -- References -- Relevant Websites -- Chapter 8: Marine Omega-3 Polyunsaturated Fatty Acids and Rheumatoid Arthritis -- Abbreviations -- 1. Introduction -- 2. Rheumatoid Arthritis -- 3. Arachidonic Acid, Eicosanoids and the Links with Inflammation and RA -- 4. Fatty Acid Modification of Immune Cell Fatty Acid Composition and of Eicosanoid Profiles -- 5. Resolvins: Novel Anti-Inflammatory and Inflammation-Resolving Mediators Produced from EPA and DHA -- 6. Influence of Marine n-3 Fatty Acids on Inflammatory Cytokines -- 6.1. Transcription Factors Involved in Regulating Inflammatory Gene Expression -- 6.2. Fatty Acid Modulation of Transcription Factor Activation and Inflammatory Cytokine Production -- 7. Influence of Marine n-3 Fatty Acids on T Cells -- 8. Influence of Marine n-3 Fatty Acids on Antigen Presentation -- 9. Marine n-3 PUFAs and Animal Models of RA -- 10. Trials of Marine n-3 PUFAs in RA. 10.1. Summary of Trials -- 10.2. Meta-Analyses -- 11. Overall Conclusions -- References -- Chapter 9: Diet Modulated Inflammation in Chronic Disease: An Overview -- 1. Introduction -- 2. Measuring Metaflammation -- 3. Nutrition and Metaflammation -- 3.1. Total Energy Intake -- 3.2. Dietary Patterns -- 3.3. Macronutrients -- 3.3.1. Dietary fats -- 3.3.2. Carbohydrates -- 3.4. Micronutrients -- 3.5. Beverages -- 4. Summary -- References -- Chapter 10: Food Supplements and Immune Function in Humans -- Abbreviations -- 1. Introduction: Nutrition and Immunity -- 1.1. The Immune System -- 1.2. Immune-Related Diseases -- 1.3. Relationships Between Nutrition and Immunity -- 2. Food Supplementation and Disease -- 2.1. Respiratory Diseases: Bronchitis, Asthma, Rhinitis -- 2.2. Food Allergies -- 2.3. Celiac Disease -- 2.4. Inflammatory Bowel Disease/Crohn's Disease -- 2.5. Atopic Dermatitis and Eczema -- 2.6. Psoriasis -- 2.7. Systemic Lupus Erythematosus -- 2.8. Rheumatoid Arthritis -- 2.9. Multiple Sclerosis -- 2.10. Cognitive Degeneration and Alzheimer's Disease -- 3. Conclusion -- Glossary -- References -- Further reading -- Chapter 11: Natural Antioxidants and Resistance to Infection -- Abbreviations -- 1. Introduction -- 2. Oxidative Stress and Antioxidant Protection -- 3. Vitamins and Host Resistance to Infection -- 3.1. Vitamin A and β-Carotene -- 3.2. Vitamin C -- 3.3. Vitamin E -- 4. Trace Elements and Host Resistance to Infection -- 4.1. Selenium -- 4.2. Iron -- 4.3. Zinc -- 4.4. Copper -- 5. Summary Points -- References -- Chapter 12: The Effects of Flavonoids on the Immune System -- Abbreviations -- 1. Introduction -- 2. Acquired Immunity: The Tailored Response Against Antigen -- 3. Flavonoids in the Immune System -- 3.1. In Vitro Studies of Flavonoids in the Immune System. 3.2. The Effect of Flavonoid Intake on the Functionality of the Immune System -- 3.2.1. Preclinical studies with single flavonoids administered orally -- 3.2.2. Preclinical studies using food extracts rich in flavonoids -- 3.2.3. Clinical studies using food or extracts rich in flavonoids -- 4. Concluding Remarks -- Glossary -- References -- Further Reading -- Chapter 13: Wheat Allergy -- Abbreviations -- 1. Allergy to Wheat and Related Diseases -- 2. Changes in Allergenic Properties of Wheat Induced by Heat and Industrial Processing -- 3. Allergen Cross-Reactivity Among Cereals, Pollen, and Other Vegetal Foods -- 4. Why Patients with Baker's Asthma Due to Wheat Tolerate Wheat Flour Ingestion? -- 5. Relationship Between Diet and Allergic Asthma -- 6. The Role of Wheat in Diabetic's Diet -- 7. Cereal Tolerance Mechanism and Treatment Possibilities -- References -- Chapter 14: Tomato Food Allergy -- Abbreviations -- 1. Food Allergy: Mechanisms, Symptoms, and Prevalence -- 2. Tomato Allergy: Prevalence and Symptoms -- 3. Tomato Allergens -- 3.1. Lyc e 1 -- 3.2. Lyc e 2 -- 3.3. Lyc e 3 -- 3.4. Lyc e 4 -- 4. Cross-reactions Among Tomato and Other Allergens -- 4.1. Pollen-Tomato Cross-reactivity -- 4.2. Latex-Pollen-Tomato Cross-reactivity -- 5. Conclusions -- Glossary -- References -- Further Reading -- Relevant Websites -- Chapter 15: Indian Medicinal Plants as Immunomodulators: Scientific Validation of the Ethnomedicinal Beliefs -- Abbreviations -- 1. Introduction -- 2. Plants as Immunomodulators -- 2.1. Ocimum sanctum Linn. or Ocimum tenuiflorum L. (Family Lamiaceae) -- 2.2. Phyllanthus emblica L. or Emblica officinalis Gaertn. (Family Phyllanthaceae) -- 2.3. Withania somnifera (L.) Dunal (Family Solanaceae) -- 2.4. Tinospora cordifolia (Thunb.) Miers (Family Menispermaceae) -- 2.5. Semecarpus anacardium Linn. (Family: Anacardiaceae). 2.6. Azadirachta indica A. Juss (Family Meliaceae). |
| Record Nr. | UNINA-9910808812803321 |
| Boston, : Elsevier, 2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Bioactive food as interventions for arthritis and related inflammatory diseases [[electronic resource] /] / edited by Ronald Ross Watson and Victor R. Preedy
| Bioactive food as interventions for arthritis and related inflammatory diseases [[electronic resource] /] / edited by Ronald Ross Watson and Victor R. Preedy |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Boston, : Elsevier, 2013 |
| Descrizione fisica | xxv, 654 p. : ill. (some col.) |
| Altri autori (Persone) |
WatsonRonald R (Ronald Ross)
PreedyVictor R |
| Collana | Bioactive foods in chronic disease states |
| Soggetto topico |
Arthritis - Nutritional aspects
Inflammation Bioactive compounds |
| Soggetto genere / forma | Electronic books. |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910468017903321 |
| Boston, : Elsevier, 2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Nutrition and arthritis [[electronic resource] /] / Margaret Rayman, Alison Callaghan
| Nutrition and arthritis [[electronic resource] /] / Margaret Rayman, Alison Callaghan |
| Autore | Rayman Margaret |
| Pubbl/distr/stampa | Oxford ; ; Ames, Iowa, : Blackwell Pub., 2006 |
| Descrizione fisica | 1 online resource (282 p.) |
| Disciplina |
616.7/220654
616.7220654 |
| Altri autori (Persone) | CallaghanAlison |
| Soggetto topico |
Arthritis - Nutritional aspects
Arthritis - Diet therapy |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-74810-9
9786610748105 0-470-76079-6 0-470-77501-7 1-4051-7287-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contents; 8.6.2 Iron status in OA and RA patients; Acknowledgements; Abbreviations; 1 Introduction; 1.1 The range of rheumatic diseases; 1.2 Rheumatoid arthritis (RA):description; 1.3 Osteoarthritis (OA):description; 1.4 Incidence and prevalence; 1.5 Mortality; 1.6 Morbidity; 1.7 Economic cost of arthritis; 1.8 The aim of this book; 2 Classification,pathology and measures of disease assessment; 2.1 Classification of OA; 2.2 Classification of RA; 2.3 Pathology of OA; 2.3.1 General features of OA; 2.3.2 Structure of cartilage; 2.3.3 Pathogenesis of OA; 2.3.3.1 Cartilage degradation
2.3.3.2 Nitric oxide synthesis damages chondrocytes2.3.3.3 Sulphation pattern of GAGs in articular cartilage; 2.3.3.4 Bone changes; 2.3.3.5 Inflammation; 2.3.3.6 Angiogenesis; 2.3.3.7 Oxidative stress; 2.4 Pathology of RA; 2.4.1 General features of RA; 2.4.2 Immunopathogenesis and production of inflammatory mediators; 2.4.3 Autoantibodies:rheumatoid factor; 2.4.4 Glycosylation patterns of immunoglobulins and complement activation; 2.4.5 Dietary lectins,gut translocation and the shared epitope; 2.4.6 Abnormal gut microflora 2.4.7 Reactive oxygen and nitrogen species involved in damage to the rheumatoid joint2.4.7.1 Phagocytosis; 2.4.7.2 Hypoxia reperfusion injury and joint pH; 2.4.7.3 Involvement of nitric oxide and peroxynitrite; 2.4.7.4 Consequences of the production of reactive oxygen and nitrogen species in the RA joint; 2.4.8 Lipid abnormalities and cardiovascular risk in RA; 2.4.8.1 C-Reactive Protein (CRP); 2.4.8.2 Dyslipidaemia; 2.4.8.3 Endothelial dysfunction; 2.4.8.4 Oxidised LDL in the joint and the formation of fatty streaks; 2.4.8.5 Adhesion molecules; 2.4.8.6 Haemostatic changes 2.4.8.7 Elevated homocysteine and low vitamin B6 status2.4.8.8 Elevated homocysteine and impaired sulphur metabolism; 2.4.8.9 Insulin resistance; 2.4.9 Angiogenesis; 2.4.10 Osteoporosis; 2.5 Assessment of severity of RA and OA; 2.5.1 Outcome measures for RA; 2.5.1.1 Patient 's global assessment; 2.5.1.2 Pain; 2.5.1.3 Disability; 2.5.1.4 Swollen and tender joint counts; 2.5.1.5 Acute phase reactants; 2.5.1.6 RA quality of life index; 2.5.1.7 Radiological assessment; 2.5.2 Some outcome measures for OA; 2.5.2.1 Patient global assessment; 2.5.2.2 Pain score; 2.5.2.3 New joint score 2.5.2.4 Severity score2.5.2.5 Disability; 2.5.2.6 Radiological assessment; 3 Aetiology and risk factors for osteoarthritis and rheumatoid arthritis; 3.1 Introduction; 3.2 Genetic risk factors; 3.3 Age; 3.4 Gender; 3.5 Biomechanical factors as risk factors for OA; 3.5.1 Occupation,sport and physical activity; 3.5.2 Joint trauma and surgery; 3.5.3 Load distribution and malalignment; 3.5.4 Muscle weakness; 3.6 Obesity; 3.7 Smoking; 3.8 Dietary factors; 3.8.1 Olive oil; 3.8.2 Fish and n-3 polyunsaturated fatty acid (PUFA); 3.8.3 Meat; 3.8.4 Fruit and vegetables; 3.8.5 Antioxidants 3.8.6 Vitamin C |
| Record Nr. | UNINA-9910143290603321 |
|
Rayman Margaret
|
||
| Oxford ; ; Ames, Iowa, : Blackwell Pub., 2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Nutrition and arthritis [[electronic resource] /] / Margaret Rayman, Alison Callaghan
| Nutrition and arthritis [[electronic resource] /] / Margaret Rayman, Alison Callaghan |
| Autore | Rayman Margaret |
| Pubbl/distr/stampa | Oxford ; ; Ames, Iowa, : Blackwell Pub., 2006 |
| Descrizione fisica | 1 online resource (282 p.) |
| Disciplina |
616.7/220654
616.7220654 |
| Altri autori (Persone) | CallaghanAlison |
| Soggetto topico |
Arthritis - Nutritional aspects
Arthritis - Diet therapy |
| ISBN |
1-280-74810-9
9786610748105 0-470-76079-6 0-470-77501-7 1-4051-7287-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contents; 8.6.2 Iron status in OA and RA patients; Acknowledgements; Abbreviations; 1 Introduction; 1.1 The range of rheumatic diseases; 1.2 Rheumatoid arthritis (RA):description; 1.3 Osteoarthritis (OA):description; 1.4 Incidence and prevalence; 1.5 Mortality; 1.6 Morbidity; 1.7 Economic cost of arthritis; 1.8 The aim of this book; 2 Classification,pathology and measures of disease assessment; 2.1 Classification of OA; 2.2 Classification of RA; 2.3 Pathology of OA; 2.3.1 General features of OA; 2.3.2 Structure of cartilage; 2.3.3 Pathogenesis of OA; 2.3.3.1 Cartilage degradation
2.3.3.2 Nitric oxide synthesis damages chondrocytes2.3.3.3 Sulphation pattern of GAGs in articular cartilage; 2.3.3.4 Bone changes; 2.3.3.5 Inflammation; 2.3.3.6 Angiogenesis; 2.3.3.7 Oxidative stress; 2.4 Pathology of RA; 2.4.1 General features of RA; 2.4.2 Immunopathogenesis and production of inflammatory mediators; 2.4.3 Autoantibodies:rheumatoid factor; 2.4.4 Glycosylation patterns of immunoglobulins and complement activation; 2.4.5 Dietary lectins,gut translocation and the shared epitope; 2.4.6 Abnormal gut microflora 2.4.7 Reactive oxygen and nitrogen species involved in damage to the rheumatoid joint2.4.7.1 Phagocytosis; 2.4.7.2 Hypoxia reperfusion injury and joint pH; 2.4.7.3 Involvement of nitric oxide and peroxynitrite; 2.4.7.4 Consequences of the production of reactive oxygen and nitrogen species in the RA joint; 2.4.8 Lipid abnormalities and cardiovascular risk in RA; 2.4.8.1 C-Reactive Protein (CRP); 2.4.8.2 Dyslipidaemia; 2.4.8.3 Endothelial dysfunction; 2.4.8.4 Oxidised LDL in the joint and the formation of fatty streaks; 2.4.8.5 Adhesion molecules; 2.4.8.6 Haemostatic changes 2.4.8.7 Elevated homocysteine and low vitamin B6 status2.4.8.8 Elevated homocysteine and impaired sulphur metabolism; 2.4.8.9 Insulin resistance; 2.4.9 Angiogenesis; 2.4.10 Osteoporosis; 2.5 Assessment of severity of RA and OA; 2.5.1 Outcome measures for RA; 2.5.1.1 Patient 's global assessment; 2.5.1.2 Pain; 2.5.1.3 Disability; 2.5.1.4 Swollen and tender joint counts; 2.5.1.5 Acute phase reactants; 2.5.1.6 RA quality of life index; 2.5.1.7 Radiological assessment; 2.5.2 Some outcome measures for OA; 2.5.2.1 Patient global assessment; 2.5.2.2 Pain score; 2.5.2.3 New joint score 2.5.2.4 Severity score2.5.2.5 Disability; 2.5.2.6 Radiological assessment; 3 Aetiology and risk factors for osteoarthritis and rheumatoid arthritis; 3.1 Introduction; 3.2 Genetic risk factors; 3.3 Age; 3.4 Gender; 3.5 Biomechanical factors as risk factors for OA; 3.5.1 Occupation,sport and physical activity; 3.5.2 Joint trauma and surgery; 3.5.3 Load distribution and malalignment; 3.5.4 Muscle weakness; 3.6 Obesity; 3.7 Smoking; 3.8 Dietary factors; 3.8.1 Olive oil; 3.8.2 Fish and n-3 polyunsaturated fatty acid (PUFA); 3.8.3 Meat; 3.8.4 Fruit and vegetables; 3.8.5 Antioxidants 3.8.6 Vitamin C |
| Record Nr. | UNISA-996205530003316 |
|
Rayman Margaret
|
||
| Oxford ; ; Ames, Iowa, : Blackwell Pub., 2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Nutrition and arthritis [[electronic resource] /] / Margaret Rayman, Alison Callaghan
| Nutrition and arthritis [[electronic resource] /] / Margaret Rayman, Alison Callaghan |
| Autore | Rayman Margaret |
| Pubbl/distr/stampa | Oxford ; ; Ames, Iowa, : Blackwell Pub., 2006 |
| Descrizione fisica | 1 online resource (282 p.) |
| Disciplina |
616.7/220654
616.7220654 |
| Altri autori (Persone) | CallaghanAlison |
| Soggetto topico |
Arthritis - Nutritional aspects
Arthritis - Diet therapy |
| ISBN |
1-280-74810-9
9786610748105 0-470-76079-6 0-470-77501-7 1-4051-7287-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contents; 8.6.2 Iron status in OA and RA patients; Acknowledgements; Abbreviations; 1 Introduction; 1.1 The range of rheumatic diseases; 1.2 Rheumatoid arthritis (RA):description; 1.3 Osteoarthritis (OA):description; 1.4 Incidence and prevalence; 1.5 Mortality; 1.6 Morbidity; 1.7 Economic cost of arthritis; 1.8 The aim of this book; 2 Classification,pathology and measures of disease assessment; 2.1 Classification of OA; 2.2 Classification of RA; 2.3 Pathology of OA; 2.3.1 General features of OA; 2.3.2 Structure of cartilage; 2.3.3 Pathogenesis of OA; 2.3.3.1 Cartilage degradation
2.3.3.2 Nitric oxide synthesis damages chondrocytes2.3.3.3 Sulphation pattern of GAGs in articular cartilage; 2.3.3.4 Bone changes; 2.3.3.5 Inflammation; 2.3.3.6 Angiogenesis; 2.3.3.7 Oxidative stress; 2.4 Pathology of RA; 2.4.1 General features of RA; 2.4.2 Immunopathogenesis and production of inflammatory mediators; 2.4.3 Autoantibodies:rheumatoid factor; 2.4.4 Glycosylation patterns of immunoglobulins and complement activation; 2.4.5 Dietary lectins,gut translocation and the shared epitope; 2.4.6 Abnormal gut microflora 2.4.7 Reactive oxygen and nitrogen species involved in damage to the rheumatoid joint2.4.7.1 Phagocytosis; 2.4.7.2 Hypoxia reperfusion injury and joint pH; 2.4.7.3 Involvement of nitric oxide and peroxynitrite; 2.4.7.4 Consequences of the production of reactive oxygen and nitrogen species in the RA joint; 2.4.8 Lipid abnormalities and cardiovascular risk in RA; 2.4.8.1 C-Reactive Protein (CRP); 2.4.8.2 Dyslipidaemia; 2.4.8.3 Endothelial dysfunction; 2.4.8.4 Oxidised LDL in the joint and the formation of fatty streaks; 2.4.8.5 Adhesion molecules; 2.4.8.6 Haemostatic changes 2.4.8.7 Elevated homocysteine and low vitamin B6 status2.4.8.8 Elevated homocysteine and impaired sulphur metabolism; 2.4.8.9 Insulin resistance; 2.4.9 Angiogenesis; 2.4.10 Osteoporosis; 2.5 Assessment of severity of RA and OA; 2.5.1 Outcome measures for RA; 2.5.1.1 Patient 's global assessment; 2.5.1.2 Pain; 2.5.1.3 Disability; 2.5.1.4 Swollen and tender joint counts; 2.5.1.5 Acute phase reactants; 2.5.1.6 RA quality of life index; 2.5.1.7 Radiological assessment; 2.5.2 Some outcome measures for OA; 2.5.2.1 Patient global assessment; 2.5.2.2 Pain score; 2.5.2.3 New joint score 2.5.2.4 Severity score2.5.2.5 Disability; 2.5.2.6 Radiological assessment; 3 Aetiology and risk factors for osteoarthritis and rheumatoid arthritis; 3.1 Introduction; 3.2 Genetic risk factors; 3.3 Age; 3.4 Gender; 3.5 Biomechanical factors as risk factors for OA; 3.5.1 Occupation,sport and physical activity; 3.5.2 Joint trauma and surgery; 3.5.3 Load distribution and malalignment; 3.5.4 Muscle weakness; 3.6 Obesity; 3.7 Smoking; 3.8 Dietary factors; 3.8.1 Olive oil; 3.8.2 Fish and n-3 polyunsaturated fatty acid (PUFA); 3.8.3 Meat; 3.8.4 Fruit and vegetables; 3.8.5 Antioxidants 3.8.6 Vitamin C |
| Record Nr. | UNINA-9910830101603321 |
|
Rayman Margaret
|
||
| Oxford ; ; Ames, Iowa, : Blackwell Pub., 2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Nutrition and arthritis / / Margaret Rayman, Alison Callaghan
| Nutrition and arthritis / / Margaret Rayman, Alison Callaghan |
| Autore | Rayman Margaret |
| Pubbl/distr/stampa | Oxford ; ; Ames, Iowa, : Blackwell Pub., 2006 |
| Descrizione fisica | 1 online resource (282 p.) |
| Disciplina | 616.7/220654 |
| Altri autori (Persone) | CallaghanAlison |
| Soggetto topico |
Arthritis - Nutritional aspects
Arthritis - Diet therapy |
| ISBN |
1-280-74810-9
9786610748105 0-470-76079-6 0-470-77501-7 1-4051-7287-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contents; 8.6.2 Iron status in OA and RA patients; Acknowledgements; Abbreviations; 1 Introduction; 1.1 The range of rheumatic diseases; 1.2 Rheumatoid arthritis (RA):description; 1.3 Osteoarthritis (OA):description; 1.4 Incidence and prevalence; 1.5 Mortality; 1.6 Morbidity; 1.7 Economic cost of arthritis; 1.8 The aim of this book; 2 Classification,pathology and measures of disease assessment; 2.1 Classification of OA; 2.2 Classification of RA; 2.3 Pathology of OA; 2.3.1 General features of OA; 2.3.2 Structure of cartilage; 2.3.3 Pathogenesis of OA; 2.3.3.1 Cartilage degradation
2.3.3.2 Nitric oxide synthesis damages chondrocytes2.3.3.3 Sulphation pattern of GAGs in articular cartilage; 2.3.3.4 Bone changes; 2.3.3.5 Inflammation; 2.3.3.6 Angiogenesis; 2.3.3.7 Oxidative stress; 2.4 Pathology of RA; 2.4.1 General features of RA; 2.4.2 Immunopathogenesis and production of inflammatory mediators; 2.4.3 Autoantibodies:rheumatoid factor; 2.4.4 Glycosylation patterns of immunoglobulins and complement activation; 2.4.5 Dietary lectins,gut translocation and the shared epitope; 2.4.6 Abnormal gut microflora 2.4.7 Reactive oxygen and nitrogen species involved in damage to the rheumatoid joint2.4.7.1 Phagocytosis; 2.4.7.2 Hypoxia reperfusion injury and joint pH; 2.4.7.3 Involvement of nitric oxide and peroxynitrite; 2.4.7.4 Consequences of the production of reactive oxygen and nitrogen species in the RA joint; 2.4.8 Lipid abnormalities and cardiovascular risk in RA; 2.4.8.1 C-Reactive Protein (CRP); 2.4.8.2 Dyslipidaemia; 2.4.8.3 Endothelial dysfunction; 2.4.8.4 Oxidised LDL in the joint and the formation of fatty streaks; 2.4.8.5 Adhesion molecules; 2.4.8.6 Haemostatic changes 2.4.8.7 Elevated homocysteine and low vitamin B6 status2.4.8.8 Elevated homocysteine and impaired sulphur metabolism; 2.4.8.9 Insulin resistance; 2.4.9 Angiogenesis; 2.4.10 Osteoporosis; 2.5 Assessment of severity of RA and OA; 2.5.1 Outcome measures for RA; 2.5.1.1 Patient 's global assessment; 2.5.1.2 Pain; 2.5.1.3 Disability; 2.5.1.4 Swollen and tender joint counts; 2.5.1.5 Acute phase reactants; 2.5.1.6 RA quality of life index; 2.5.1.7 Radiological assessment; 2.5.2 Some outcome measures for OA; 2.5.2.1 Patient global assessment; 2.5.2.2 Pain score; 2.5.2.3 New joint score 2.5.2.4 Severity score2.5.2.5 Disability; 2.5.2.6 Radiological assessment; 3 Aetiology and risk factors for osteoarthritis and rheumatoid arthritis; 3.1 Introduction; 3.2 Genetic risk factors; 3.3 Age; 3.4 Gender; 3.5 Biomechanical factors as risk factors for OA; 3.5.1 Occupation,sport and physical activity; 3.5.2 Joint trauma and surgery; 3.5.3 Load distribution and malalignment; 3.5.4 Muscle weakness; 3.6 Obesity; 3.7 Smoking; 3.8 Dietary factors; 3.8.1 Olive oil; 3.8.2 Fish and n-3 polyunsaturated fatty acid (PUFA); 3.8.3 Meat; 3.8.4 Fruit and vegetables; 3.8.5 Antioxidants 3.8.6 Vitamin C |
| Altri titoli varianti | Nutrition & arthritis |
| Record Nr. | UNINA-9910877057703321 |
|
Rayman Margaret
|
||
| Oxford ; ; Ames, Iowa, : Blackwell Pub., 2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
